Rani-Puren en es it fr

Rani-Puren Brand names, Rani-Puren Analogs

Rani-Puren Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Rani-Puren Chemical_Formula


Rani-Puren RX_link


Rani-Puren fda sheet

Rani-Puren FDA

Rani-Puren msds (material safety sheet)

Rani-Puren MSDS

Rani-Puren Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Rani-Puren Molecular Weight

314.405 g/mol

Rani-Puren Melting Point

69-70 oC

Rani-Puren H2O Solubility

24.7 mg/mL

Rani-Puren State


Rani-Puren LogP


Rani-Puren Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Rani-Puren Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Rani-Puren Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Rani-Puren Absorption

Approximately 50% bioavailability orally.

Rani-Puren side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Rani-Puren Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Rani-Puren Organisms Affected

Humans and other mammals